Skip to main content
. 2013 Mar 26;19(5):858–866. doi: 10.1007/s10156-013-0580-2

Fig. 1.

Fig. 1

Serum concentration–time profiles of sitafloxacin in patients with respiratory tract infection (RTI) (left: open circles 100 mg, n = 28; filled circles 50 mg, n = 109; total 137 patients) and in subjects participating in clinical pharmacology studies (right: 25, 50, 100, or 200 mg; total 75 subjects)